Tag Archives: Merger

Novartis takes total control of Alcon

In a $28Bn USD operation, the Swiss Pharmaceutical buys the 52% of Alcon’s remanent stock from Nestlé. Novartis would own an approximate 77 percent interest in Alcon. The operation goes at least one and a half year earlier than estimated in … Continue reading

Posted in Alta Dirección, Mercadotecnia, Salud | Tagged , , , , , , , , , , , , , , | Leave a comment

Abbott buys Solvay Pharma Division on $7Bn USD

According to information published today at the Wall Street Journal, Abbott will buy Solvay’s Pharmaceutical Division in a $7Bn USD deal. The official communication could be published by both companies as early as monday morning. With this deal Abbott is … Continue reading

Posted in Alta Dirección, Mercadotecnia, Ventas | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

2009 Pharma Mergers. A comprehensive analysis facing the future.

The last two months have been full of surprises in the Pharmaceutical arena. January was not even ending, when Pfizer was announcing its intentions of taking over Wyeth. Just some days after a month later and after a more-than-nervous weekend, … Continue reading

Posted in Alta Dirección, Mercadotecnia, Opinión, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 3 Comments

De Dinosaurios, Sexo y Fusiones.

El analista farmacéutico español Miguel A. Tovar comenta en Blogaceutics, su blog especializado en la Industria Farmacéutica sobre la fusión entre Merck y Schering-Plough. Documentado como siempre, Miguel se muestra escéptico ante el éxito que pueda tener a futuro esta operación. Comparando esta … Continue reading

Posted in Alta Dirección, Blogs, Opinión, Salud, Web | Tagged , , , , , , , , , | Leave a comment

Merck will buy Schering-Plough for $41.1 Bn USD

By Xavier Tello Merck (or Merck Sharp & Dohme) will buy Schering- Plough for $41.1Bn USD in cash and stock, according to Bloomberg and Reuters. Despite the speculations during the weekend that J&J could be a stronger bidder, and Merck’s … Continue reading

Posted in Alta Dirección, Mercadotecnia, Planeac. Estratégica, Ventas | Tagged , , , , , , , , , , , , | 1 Comment